                         SEQUENCE LISTING

<110>  Ascendis Pharma Oncology Division A/S
 
<120>  Glycosylated IL-2 proteins and uses thereof

<130>  CPX73073PC

<160>  368   

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  PRT
<213>  Human

<400>  1

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn 
            20                  25                  


<210>  2
<211>  46
<212>  PRT
<213>  Human

<400>  2

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  3
<211>  57
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ C with C49S

<400>  3

Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile 
1               5                   10                  15      


Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala 
            20                  25                  30          


Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe 
        35                  40                  45              


Ser Gln Ser Ile Ile Ser Thr Leu Thr 
    50                  55          


<210>  4
<211>  57
<212>  PRT
<213>  Human

<400>  4

Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile 
1               5                   10                  15      


Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala 
            20                  25                  30          


Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe 
        35                  40                  45              


Cys Gln Ser Ile Ile Ser Thr Leu Thr 
    50                  55          


<210>  5
<211>  153
<212>  PRT
<213>  Human

<400>  5

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu 
            20                  25                  30          


Gln Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile 
        35                  40                  45              


Asn Asn Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe 
    50                  55                  60                  


Tyr Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu 
65                  70                  75                  80  


Glu Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
                85                  90                  95      


Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile 
            100                 105                 110         


Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala 
        115                 120                 125             


Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe 
    130                 135                 140                 


Cys Gln Ser Ile Ile Ser Thr Leu Thr 
145                 150             


<210>  6
<211>  133
<212>  PRT
<213>  Human

<400>  6

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  7
<211>  486
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence for protein 1a

<400>  7
atggatatgc gggtccctgc tcagctgctg ggcctgctgc tgctgtggtt tcctgggtca       60

aggtgcgccc ccacatctag ttctacaaag aagacacaat tacaattaga gcacttatta      120

ttagacttac aaatgatatt aaatggcata aataattata agaatcccaa gttaactttc      180

ggcaacagca ccaagtttta tatgcctaag aaggctacag agttaaagca cttacaatgt      240

ttagaggagg agttaaagcc attagaggag gtattaaatt tagcccaatc aaagaatttt      300

cacttacggc cccgggactt aatttccaat attaatgtta ttgtgttaga gttaaagggc      360

tctgagacaa cttttatgtg tgagtatgcc gacgagacag ccacaattgt tgagttctta      420

aatcggtgga ttactttttc acaatccatt atctccactt taactcatca tcaccatcac      480

cactaa                                                                 486


<210>  8
<211>  486
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence for protein 1b

<400>  8
atggatatgc gggtccctgc tcagctgctg ggcctgctgc tgctgtggtt tcctgggtca       60

aggtgcgccc ccacatctag ttctacaaag aagacacaat tacaattaga gcacttatta      120

ttagacttac aaatgatatt aaatggcata aataattata agaatcccaa gttaactaga      180

atgttattcg gcaacagcac catgcctaag aaggctacag agttaaagca cttacaatgt      240

ttagaggagg agttaaagcc attagaggag gtattaaatt tagcccaatc aaagaatttt      300

cacttacggc cccgggactt aatttccaat attaatgtta ttgtgttaga gttaaagggc      360

tctgagacaa cttttatgtg tgagtatgcc gacgagacag ccacaattgt tgagttctta      420

aatcggtgga ttactttttc acaatccatt atctccactt taactcatca tcaccatcac      480

cactaa                                                                 486


<210>  9
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  9

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  10
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  10

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  11
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  11

Tyr Lys Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  12
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  12

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  13
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  13

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  14
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  14

Tyr Lys Asn Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  15
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  15

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  16
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  16

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  17
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  17

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  18
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  18

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  19
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  19

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  20
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  20

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  21
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  21

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  22
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  22

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  23
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  23

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly 
            20                  25                  30          


Asn Ser Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  24
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  24

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  25
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  25

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  26
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  26

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala 
            20                  25                  30          


Asn Ser Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  27
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  27

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  28
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  28

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  29
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  29

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  30
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  30

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  31
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  31

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  32
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  32

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys 
        35                  40                  45      


<210>  33
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  33

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  34
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  34

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  35
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  35

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys 
        35                  40                  45      


<210>  36
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  36

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn 
            20                  25                  


<210>  37
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  37

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  38
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  38

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  39
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  39

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  40
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  40

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  41
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  41

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  42
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  42

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  43
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  43

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  44
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  44

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  45
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  45

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  46
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  46

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  47
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  47

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  48
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  48

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  49
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  49

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  50
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  50

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  51
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  51

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  52
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  52

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  53
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  53

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  54
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  54

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  55
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  55

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  56
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  56

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  57
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  57

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  58
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  58

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  59
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  59

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  60
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  60

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Ala Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  61
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  61

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  62
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  62

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  63
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  63

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  64
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  64

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  65
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  65

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  66
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  66

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  67
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  67

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  68
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  68

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  69
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  69

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  70
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  70

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  71
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  71

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  72
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  72

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  73
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  73

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  74
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  74

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  75
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  75

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  76
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  76

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  77
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  77

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  78
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  78

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Ala Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  79
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  79

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  80
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  80

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  81
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  81

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  82
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  82

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  83
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  83

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  84
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  84

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Phe Gly Asn Ser Thr Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  85
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  T, S or C

<400>  85

Asn Xaa Xaa Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  86
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  T, S or C

<400>  86

Tyr Asn Xaa Xaa Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  87
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  T, S or C

<400>  87

Tyr Lys Asn Xaa Xaa Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  88
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  T, S or C

<400>  88

Tyr Lys Asn Asn Xaa Xaa Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  89
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  T, S or C

<400>  89

Tyr Lys Asn Pro Asn Xaa Xaa Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  90
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  T, S or C

<400>  90

Tyr Lys Asn Pro Lys Asn Xaa Xaa Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  91
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  T, S or C

<400>  91

Tyr Lys Asn Pro Lys Leu Asn Xaa Xaa Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  92
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  T, S or C

<400>  92

Tyr Lys Asn Pro Lys Leu Thr Asn Xaa Xaa Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  93
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  T, S or C

<400>  93

Tyr Lys Asn Pro Lys Leu Thr Arg Asn Xaa Xaa Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  94
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  T, S or C

<400>  94

Tyr Lys Asn Pro Lys Leu Thr Arg Met Asn Xaa Xaa Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  95
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  T, S or C

<400>  95

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Asn Xaa Xaa Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  96
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  T, S or C

<400>  96

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Asn Xaa Xaa Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  97
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  T, S or C

<400>  97

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Asn Xaa Xaa Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  98
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  T, S or C

<400>  98

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Asn Xaa Xaa 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  99
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  T, S or C

<400>  99

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Asn Xaa 
1               5                   10                  15      


Xaa Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  100
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  T, S or C

<400>  100

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Asn 
1               5                   10                  15      


Xaa Xaa Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  101
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  T, S or C

<400>  101

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Asn Xaa Xaa Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  102
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  T, S or C

<400>  102

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Asn Xaa Xaa Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  103
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  T, S or C

<400>  103

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Asn Xaa Xaa Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  104
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  T, S or C

<400>  104

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Asn Xaa Xaa Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  105
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  T, S or C

<400>  105

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Asn Xaa Xaa Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  106
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  T, S or C

<400>  106

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Asn Xaa Xaa His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  107
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  T, S or C

<400>  107

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Asn Xaa Xaa Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  108
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  T, S or C

<400>  108

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Asn Xaa Xaa Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  109
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  T, S or C

<400>  109

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys Asn Xaa Xaa Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  110
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  T, S or C

<400>  110

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Asn Xaa Xaa Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  111
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  T, S or C

<400>  111

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Asn Xaa Xaa Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  112
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  112

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Asn Ser 
            20                  25                  30          


Thr Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  113
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  T, S or C

<400>  113

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Asn Xaa Xaa Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  114
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  T, S or C

<400>  114

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Asn Xaa Xaa Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  115
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  T, S or C

<400>  115

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Asn Xaa Xaa 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  116
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  T, S or C

<400>  116

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Asn Xaa 
            20                  25                  30          


Xaa Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  117
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (34)..(34)
<223>  T, S or C

<400>  117

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Asn 
            20                  25                  30          


Xaa Xaa Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  118
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (34)..(34)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  T, S or C

<400>  118

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Asn Xaa Xaa Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  119
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  T, S or C

<400>  119

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Asn Xaa Xaa Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  120
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  T, S or C

<400>  120

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Asn Xaa Xaa Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  121
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (38)..(38)
<223>  T, S or C

<400>  121

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Asn Xaa Xaa Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  122
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (38)..(38)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  T, S or C

<400>  122

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Asn Xaa Xaa Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  123
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  T, S or C

<400>  123

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Asn Xaa Xaa Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  124
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  T, S or C

<400>  124

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Asn Xaa Xaa Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  125
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  T, S or C

<400>  125

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Asn Xaa Xaa Ala Gln Ser Lys 
        35                  40                  45      


<210>  126
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  T, S or C

<400>  126

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Xaa Xaa Gln Ser Lys 
        35                  40                  45      


<210>  127
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  T, S or C

<400>  127

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Asn Xaa Xaa Ser Lys 
        35                  40                  45      


<210>  128
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  T, S or C

<400>  128

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Asn Xaa Xaa Lys 
        35                  40                  45      


<210>  129
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (46)..(46)
<223>  T, S or C

<400>  129

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Asn Xaa Xaa 
        35                  40                  45      


<210>  130
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  T, S or C

<400>  130

Xaa Xaa Asn Xaa Xaa Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  131
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  T, S or C

<400>  131

Tyr Xaa Xaa Asn Xaa Xaa Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  132
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  T, S or C

<400>  132

Tyr Lys Xaa Xaa Asn Xaa Xaa Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  133
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  T, S or C

<400>  133

Tyr Lys Asn Xaa Xaa Asn Xaa Xaa Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  134
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  T, S or C

<400>  134

Tyr Lys Asn Pro Xaa Xaa Asn Xaa Xaa Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  135
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  T, S or C

<400>  135

Tyr Lys Asn Pro Lys Xaa Xaa Asn Xaa Xaa Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  136
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  136

Tyr Lys Asn Pro Lys Leu Xaa Xaa Asn Xaa Xaa Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  137
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  T, S or C

<400>  137

Tyr Lys Asn Pro Lys Leu Thr Xaa Xaa Asn Xaa Xaa Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  138
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  T, S or C

<400>  138

Tyr Lys Asn Pro Lys Leu Thr Arg Xaa Xaa Asn Xaa Xaa Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  139
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  T, S or C

<400>  139

Tyr Lys Asn Pro Lys Leu Thr Arg Met Xaa Xaa Asn Xaa Xaa Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  140
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  T, S or C
<222>  (15)..(15)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  140

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Xaa Xaa Asn Xaa Xaa Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  141
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  T, S or C

<400>  141

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Xaa Xaa Asn Xaa Xaa 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  142
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  T, S or C

<400>  142

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Xaa Xaa Asn Xaa 
1               5                   10                  15      


Xaa Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  143
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  T, S or C

<400>  143

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Xaa Xaa Asn 
1               5                   10                  15      


Xaa Xaa Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  144
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  T, S or C

<400>  144

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Xaa Xaa 
1               5                   10                  15      


Asn Xaa Xaa Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  145
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  T, S or C

<400>  145

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Xaa 
1               5                   10                  15      


Xaa Asn Xaa Xaa Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  146
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  T, S or C

<400>  146

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Xaa Xaa Asn Xaa Xaa Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  147
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  T, S or C

<400>  147

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Xaa Xaa Asn Xaa Xaa Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  148
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  T, S or C

<400>  148

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Xaa Xaa Asn Xaa Xaa Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  149
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  T, S or C

<400>  149

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Xaa Xaa Asn Xaa Xaa His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  150
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  T, S or C

<400>  150

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Xaa Xaa Asn Xaa Xaa Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  151
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  T, S or C

<400>  151

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Xaa Xaa Asn Xaa Xaa Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  152
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  T, S or C

<400>  152

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Xaa Xaa Asn Xaa Xaa Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  153
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  T, S or C

<400>  153

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Xaa Xaa Asn Xaa Xaa Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  154
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  T, S or C

<400>  154

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys Xaa Xaa Asn Xaa Xaa Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  155
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  T, S or C

<400>  155

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Xaa Xaa Asn Xaa Xaa Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  156
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  T, S or C

<400>  156

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Xaa Xaa Asn Xaa Xaa Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  157
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  T, S or C

<400>  157

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Xaa Xaa Asn Xaa Xaa 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  158
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  T, S or C

<400>  158

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Xaa Xaa Asn Xaa 
            20                  25                  30          


Xaa Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  159
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (34)..(34)
<223>  T, S or C

<400>  159

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Xaa Xaa Asn 
            20                  25                  30          


Xaa Xaa Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  160
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (34)..(34)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  T, S or C

<400>  160

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Xaa Xaa 
            20                  25                  30          


Asn Xaa Xaa Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  161
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  T, S or C

<400>  161

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Xaa 
            20                  25                  30          


Xaa Asn Xaa Xaa Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  162
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (34)..(34)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  T, S or C

<400>  162

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Xaa Xaa Asn Xaa Xaa Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  163
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (34)..(34)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (38)..(38)
<223>  T, S or C

<400>  163

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Xaa Xaa Asn Xaa Xaa Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  164
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (38)..(38)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  T, S or C

<400>  164

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Xaa Xaa Asn Xaa Xaa Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  165
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  T, S or C

<400>  165

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Xaa Xaa Asn Xaa Xaa Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  166
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (38)..(38)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  T, S or C

<400>  166

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Xaa Xaa Asn Xaa Xaa Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  167
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (38)..(38)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  T, S or C

<400>  167

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Xaa Xaa Asn Xaa Xaa Ala Gln Ser Lys 
        35                  40                  45      


<210>  168
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  T, S or C

<400>  168

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Xaa Xaa Asn Xaa Xaa Gln Ser Lys 
        35                  40                  45      


<210>  169
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  T, S or C

<400>  169

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Xaa Xaa Asn Xaa Xaa Ser Lys 
        35                  40                  45      


<210>  170
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  T, S or C

<400>  170

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Xaa Xaa Asn Xaa Xaa Lys 
        35                  40                  45      


<210>  171
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif


<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  any proteinogenic or non-proteinogenic amino acid

<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (46)..(46)
<223>  T, S or C

<400>  171

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Xaa Xaa Asn Xaa Xaa 
        35                  40                  45      


<210>  172
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  172

Tyr Lys Asn Pro Asn Ser Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  173
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  173

Tyr Lys Asn Pro Lys Leu Thr Asn Ser Thr Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  174
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  174

Tyr Lys Asn Pro Lys Leu Thr Arg Asn Ser Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  175
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  175

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Asn Ser Thr Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  176
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  176

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Asn Ser Thr Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  177
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  177

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Asn Ser Thr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  178
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  178

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Asn Ser Thr 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  179
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  179

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Asn Ser 
1               5                   10                  15      


Thr Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  180
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  180

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Asn 
            20                  25                  30          


Ser Thr Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  181
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  181

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Asn Ser Thr Ser Lys 
        35                  40                  45      


<210>  182
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  182

Tyr Lys Asn Pro Phe Ala Asn Ser Thr Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  183
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  183

Tyr Lys Asn Pro Lys Leu Thr Arg Phe Ala Asn Ser Thr Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  184
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  184

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Ala Asn Ser Thr 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  185
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  185

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Phe Ala Asn Ser 
1               5                   10                  15      


Thr Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  186
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  186

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Ala Asn 
1               5                   10                  15      


Ser Thr Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  187
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  187

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Phe Ala 
1               5                   10                  15      


Asn Ser Thr Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  188
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  188

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Phe 
            20                  25                  30          


Ala Asn Ser Thr Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  189
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  189

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Phe Ala Asn Ser Thr 
        35                  40                  45      


<210>  190
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  190

Tyr Lys Asn Pro Phe Gly Asn Ser Thr Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  191
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  191

Tyr Lys Asn Pro Lys Leu Thr Arg Phe Gly Asn Ser Thr Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  192
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  192

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Gly Asn Ser Thr 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  193
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  193

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Phe Gly Asn Ser 
1               5                   10                  15      


Thr Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  194
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  194

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Gly Asn 
1               5                   10                  15      


Ser Thr Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  195
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  195

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Phe Gly 
1               5                   10                  15      


Asn Ser Thr Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  196
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  196

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Phe 
            20                  25                  30          


Gly Asn Ser Thr Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  197
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  197

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Phe Gly Asn Ser Thr 
        35                  40                  45      


<210>  198
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  198

Tyr Lys Asn Ser Thr Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  199
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  199

Phe Ala Asn Ser Thr Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  200
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  200

Phe Gly Asn Ser Thr Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  201
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  201

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Ser Thr Gln Ser Lys 
        35                  40                  45      


<210>  202
<211>  486
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequences for protein 1c

<400>  202
atggatatgc gggtccctgc tcagctgctg ggcctgctgc tgctgtggtt tcctgggtca       60

aggtgcgccc ccacatctag ttctacaaag aagacacaat tacaattaga gcacttatta      120

ttagacttac aaatgatatt aaatggcata aataattata agaatcccaa gttaactaga      180

atgttaacat tcaagtttta tatgcctaag aaggctacag agttaaagca cttacaatgt      240

ttagagttcg gcaacagcac cttagaggag gtattaaatt tagcccaatc aaagaatttt      300

cacttacggc cccgggactt aatttccaat attaatgtta ttgtgttaga gttaaagggc      360

tctgagacaa cttttatgtg tgagtatgcc gacgagacag ccacaattgt tgagttctta      420

aatcggtgga ttactttttc acaatccatt atctccactt taactcatca tcaccatcac      480

cactaa                                                                 486


<210>  203
<211>  486
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence for protein 1d

<400>  203
atggatatgc gggtccctgc tcagctgctg ggcctgctgc tgctgtggtt tcctgggtca       60

aggtgcgccc ccacatctag ttctacaaag aagacacaat tacaattaga gcacttatta      120

ttagacttac aaatgatatt aaatggcata aataattata agaatcccaa gttaactaga      180

atgttaacat tcaagtttta tatgcctaag aaggctacag agttaaagca cttacaatgt      240

ttagaggagg agttaaagcc attagaggag gtattaaatt tagcccaatc aaagaatttt      300

cacttacggc cccgggactt aatttccaat attaatgtta ttgtgttaga gttaaagggc      360

tctgagacaa cttttatgtg tgagtatgcc gacgagacag ccacaattgt tgagttctta      420

aatcggtgga ttactttttc acaatccatt atctccactt taactcatca tcaccatcac      480

cactaa                                                                 486


<210>  204
<211>  138
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  204

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr His His His His His His 
    130                 135             


<210>  205
<211>  139
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  205

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr His His His His His His 
    130                 135                 


<210>  206
<211>  138
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  206

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr His His His His His His 
    130                 135             


<210>  207
<211>  139
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  207

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr His His His His His His 
    130                 135                 


<210>  208
<211>  138
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  208

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr His His His His His His 
    130                 135             


<210>  209
<211>  139
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  209

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr His His His His His His 
    130                 135                 


<210>  210
<211>  138
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  210

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr His His His His His His 
    130                 135             


<210>  211
<211>  139
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  211

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr His His His His His His 
    130                 135                 


<210>  212
<211>  57
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ C with C49A

<400>  212

Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile 
1               5                   10                  15      


Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala 
            20                  25                  30          


Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe 
        35                  40                  45              


Ala Gln Ser Ile Ile Ser Thr Leu Thr 
    50                  55          


<210>  213
<211>  134
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant

<400>  213

Met Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu 
1               5                   10                  15      


His Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr 
            20                  25                  30          


Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro 
        35                  40                  45              


Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu 
    50                  55                  60                  


Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His 
65                  70                  75                  80  


Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu 
                85                  90                  95      


Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr 
            100                 105                 110         


Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ala Gln Ser 
        115                 120                 125             


Ile Ile Ser Thr Leu Thr 
    130                 


<210>  214
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  214

Tyr Lys Asn Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  215
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif

<400>  215

Tyr Lys Asn Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  216
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  216

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  217
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  217

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  218
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  218

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  219
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  219

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  220
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  220

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  221
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  221

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  222
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  222

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  223
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  223

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Asp Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  224
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  224

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  225
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  225

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  226
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  226

Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  227
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  227

Ala Pro Ala Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  228
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif

<400>  228

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Glu Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Cys Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  229
<211>  139
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  229

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asn Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr His His His His His His 
    130                 135                 


<210>  230
<211>  139
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and His-tag

<400>  230

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asn Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr His His His His His His 
    130                 135                 


<210>  231
<211>  147
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with glycosylation motif and cleavable His-tag

<400>  231

Ala His His His His His His Gly Ser Asp Asp Asp Asp Lys Ala Pro 
1               5                   10                  15      


Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu Leu 
            20                  25                  30          


Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn Pro 
        35                  40                  45              


Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr Met Pro Lys Lys Ala 
    50                  55                  60                  


Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro Leu 
65                  70                  75                  80  


Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg Pro 
                85                  90                  95      


Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys Gly 
            100                 105                 110         


Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr Ile 
        115                 120                 125             


Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile Ser 
    130                 135                 140                 


Thr Leu Thr 
145         


<210>  232
<211>  139
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 variant with His-tag

<400>  232

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr His His His His His His 
    130                 135                 


<210>  233
<211>  510
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence encoding protein 1e

<400>  233
atggatatgc gggtccctgc tcagctgctg ggcctgctgc tgctgtggtt tcctgggtca       60

aggtgcgccc atcatcacca tcaccacggc agcgacgacg acgacaaggc ccccacatct      120

agttctacaa agaagacaca attacaatta gagcacttat tattagactt acaaatgata      180

ttaaatggca taaataatta taagaatccc aagttaactt tcggcaacag caccaagttt      240

tatatgccta agaaggctac agagttaaag cacttacaat gtttagagga ggagttaaag      300

ccattagagg aggtattaaa tttagcccaa tcaaagaatt ttcacttacg gccccgggac      360

ttaatttcca atattaatgt tattgtgtta gagttaaagg gctctgagac aacttttatg      420

tgtgagtatg ccgacgagac agccacaatt gttgagttct taaatcggtg gattactttt      480

tcacaatcca ttatctccac tttaacttaa                                       510


<210>  234
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  His tag

<400>  234

Ala His His His His His His Gly Ser Asp Asp Asp Asp Lys 
1               5                   10                  


<210>  235
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif FANST

<400>  235

Tyr Lys Asn Pro Asp Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  236
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ B with glycosylation motif FANST

<400>  236

Tyr Lys Asn Pro Glu Leu Thr Phe Ala Asn Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  237
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein 2a

<400>  237

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Cys Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  238
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Signal peptide 3a

<400>  238

Met Ala Trp Lys Thr Leu Pro Ile Tyr Leu Leu Leu Leu Leu Ser Val 
1               5                   10                  15      


Phe Val Ile Gln Gln Val Ser Ser 
            20                  


<210>  239
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Signal peptide 3b

<400>  239

Met Glu Phe Gly Leu Ser Trp Val Phe Leu Val Ala Ile Ile Lys Gly 
1               5                   10                  15      


Val Gln Cys 
            


<210>  240
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Signal peptide 3c

<400>  240

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser 
            20  


<210>  241
<211>  471
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence encoding protein 2b

<400>  241
atggcctgga agactctccc catctacctc ctgctgctcc tgtcggtctt cgtcatccag       60

caggtgtcct ccgcccccac gtcgtcctcc accaagaaga cccagctgca gctcgagcac      120

ctcctgctgg acctgcagat gatcctgaac gggatcaaca actacaagaa cccgaagctg      180

acttgcatgc tgaccttcaa gttctacatg ccgaagaagg cgaccgagct gaagcacctg      240

cagtgcctgg aggaggagct caagccgctc gaggaggtgc tgaatctggc ccagtccaag      300

aacttccacc tgcgcccgcg ggacctcatc agcaacatca acgtcatcgt gctggagctg      360

aagggcagcg agacgacgtt tatgtgcgag tacgcagacg agacggccac catcgtcgag      420

ttcttgaacc ggtggatcac cttcagccag tccatcatct ccaccctgac c               471


<210>  242
<211>  456
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence encoding protein 2d

<400>  242
atggagttcg gtctgtcctg ggtgttcctg gtcgccatca tcaagggcgt gcagtgcgcc       60

cccacgtcgt cctccaccaa gaagacccag ctgcagctcg agcacctcct gctggacctg      120

cagatgatcc tgaacgggat caacaactac aagaacccga agctgacttg catgctgacc      180

ttcaagttct acatgccgaa gaaggcgacc gagctgaagc acctgcagtg cctggaggag      240

gagctcaagc cgctcgagga ggtgctgaat ctggcccagt ccaagaactt ccacctgcgc      300

ccgcgggacc tcatcagcaa catcaacgtc atcgtgctgg agctgaaggg cagcgagacg      360

acgtttatgt gcgagtacgc agacgagacg gccaccatcg tcgagttctt gaaccggtgg      420

atcaccttca gccagtccat catctccacc ctgacc                                456


<210>  243
<211>  459
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence encoding protein 2c

<400>  243
atgtaccgta tgcagctgct ctcgtgcatc gcactgagcc tcgccctggt gaccaactca       60

gcccccacgt cgtcctccac caagaagacc cagctgcagc tcgagcacct cctgctggac      120

ctgcagatga tcctgaacgg gatcaacaac tacaagaacc cgaagctgac ttgcatgctg      180

accttcaagt tctacatgcc gaagaaggcg accgagctga agcacctgca gtgcctggag      240

gaggagctca agccgctcga ggaggtgctg aatctggccc agtccaagaa cttccacctg      300

cgcccgcggg acctcatcag caacatcaac gtcatcgtgc tggagctgaa gggcagcgag      360

acgacgttta tgtgcgagta cgcagacgag acggccacca tcgtcgagtt cttgaaccgg      420

tggatcacct tcagccagtc catcatctcc accctgacc                             459


<210>  244
<211>  471
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence encoding protein 2e

<400>  244
atggcctgga agactctccc catctacctc ctgctgctcc tgtcggtctt cgtcatccag       60

caggtgtcct ccgcgcccac ttcctcgtcc accaagaaga cccagctgca gctcgaacac      120

ctgctcctcg acctccagat gatcctcaac ggaatcaaca actacaagaa ccccaagctg      180

acgttcggca actccaccaa gttctacatg cccaagaagg ccaccgagct gaagcatctg      240

cagtgcctgg aagaggagct caagccgctc gaggaagtgc tgaacctggc ccagagcaag      300

aacttccacc tccgcccgag ggacctgatc tcgaacatca acgtcatcgt gctggagctg      360

aagggatcgg agaccacgtt catgtgcgaa tacgccgacg agacggccac catcgtggag      420

ttcctcaacc gctggatcac cttctcccag agcataatct ccaccctgac c               471


<210>  245
<211>  456
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence encoding protein 2g

<400>  245
atggagttcg gtctgtcctg ggtgttcctg gtcgccatca tcaagggcgt gcagtgcgcg       60

cccacttcct cgtccaccaa gaagacccag ctgcagctcg aacacctgct cctcgacctc      120

cagatgatcc tcaacggaat caacaactac aagaacccca agctgacgtt cggcaactcc      180

accaagttct acatgcccaa gaaggccacc gagctgaagc atctgcagtg cctggaagag      240

gagctcaagc cgctcgagga agtgctgaac ctggcccaga gcaagaactt ccacctccgc      300

ccgagggacc tgatctcgaa catcaacgtc atcgtgctgg agctgaaggg atcggagacc      360

acgttcatgt gcgaatacgc cgacgagacg gccaccatcg tggagttcct caaccgctgg      420

atcaccttct cccagagcat aatctccacc ctgacc                                456


<210>  246
<211>  459
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence encoding protein 2f

<400>  246
atgtaccgca tgcagctgct gtcgtgcatc gcgctcagcc tggcgctggt cacgaactcg       60

gcgcccactt cctcgtccac caagaagacc cagctgcagc tcgaacacct gctcctcgac      120

ctccagatga tcctcaacgg aatcaacaac tacaagaacc ccaagctgac gttcggcaac      180

tccaccaagt tctacatgcc caagaaggcc accgagctga agcatctgca gtgcctggaa      240

gaggagctca agccgctcga ggaagtgctg aacctggccc agagcaagaa cttccacctc      300

cgcccgaggg acctgatctc gaacatcaac gtcatcgtgc tggagctgaa gggatcggag      360

accacgttca tgtgcgaata cgccgacgag acggccacca tcgtggagtt cctcaaccgc      420

tggatcacct tctcccagag cataatctcc accctgacc                             459


<210>  247
<211>  157
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein 2b

<400>  247

Met Ala Trp Lys Thr Leu Pro Ile Tyr Leu Leu Leu Leu Leu Ser Val 
1               5                   10                  15      


Phe Val Ile Gln Gln Val Ser Ser Ala Pro Thr Ser Ser Ser Thr Lys 
            20                  25                  30          


Lys Thr Gln Leu Gln Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile 
        35                  40                  45              


Leu Asn Gly Ile Asn Asn Tyr Lys Asn Pro Lys Leu Thr Cys Met Leu 
    50                  55                  60                  


Thr Phe Lys Phe Tyr Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu 
65                  70                  75                  80  


Gln Cys Leu Glu Glu Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu 
                85                  90                  95      


Ala Gln Ser Lys Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn 
            100                 105                 110         


Ile Asn Val Ile Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met 
        115                 120                 125             


Cys Glu Tyr Ala Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg 
    130                 135                 140                 


Trp Ile Thr Phe Ser Gln Ser Ile Ile Ser Thr Leu Thr 
145                 150                 155         


<210>  248
<211>  157
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein 2e

<400>  248

Met Ala Trp Lys Thr Leu Pro Ile Tyr Leu Leu Leu Leu Leu Ser Val 
1               5                   10                  15      


Phe Val Ile Gln Gln Val Ser Ser Ala Pro Thr Ser Ser Ser Thr Lys 
            20                  25                  30          


Lys Thr Gln Leu Gln Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile 
        35                  40                  45              


Leu Asn Gly Ile Asn Asn Tyr Lys Asn Pro Lys Leu Thr Phe Gly Asn 
    50                  55                  60                  


Ser Thr Lys Phe Tyr Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu 
65                  70                  75                  80  


Gln Cys Leu Glu Glu Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu 
                85                  90                  95      


Ala Gln Ser Lys Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn 
            100                 105                 110         


Ile Asn Val Ile Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met 
        115                 120                 125             


Cys Glu Tyr Ala Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg 
    130                 135                 140                 


Trp Ile Thr Phe Ser Gln Ser Ile Ile Ser Thr Leu Thr 
145                 150                 155         


<210>  249
<211>  152
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein 2d

<400>  249

Met Glu Phe Gly Leu Ser Trp Val Phe Leu Val Ala Ile Ile Lys Gly 
1               5                   10                  15      


Val Gln Cys Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln 
            20                  25                  30          


Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn 
        35                  40                  45              


Asn Tyr Lys Asn Pro Lys Leu Thr Cys Met Leu Thr Phe Lys Phe Tyr 
    50                  55                  60                  


Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu 
65                  70                  75                  80  


Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn 
                85                  90                  95      


Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val 
            100                 105                 110         


Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp 
        115                 120                 125             


Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser 
    130                 135                 140                 


Gln Ser Ile Ile Ser Thr Leu Thr 
145                 150         


<210>  250
<211>  152
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein 2g

<400>  250

Met Glu Phe Gly Leu Ser Trp Val Phe Leu Val Ala Ile Ile Lys Gly 
1               5                   10                  15      


Val Gln Cys Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln 
            20                  25                  30          


Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn 
        35                  40                  45              


Asn Tyr Lys Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe Tyr 
    50                  55                  60                  


Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu 
65                  70                  75                  80  


Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn 
                85                  90                  95      


Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val 
            100                 105                 110         


Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp 
        115                 120                 125             


Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser 
    130                 135                 140                 


Gln Ser Ile Ile Ser Thr Leu Thr 
145                 150         


<210>  251
<211>  153
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein 2c

<400>  251

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu 
            20                  25                  30          


Gln Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile 
        35                  40                  45              


Asn Asn Tyr Lys Asn Pro Lys Leu Thr Cys Met Leu Thr Phe Lys Phe 
    50                  55                  60                  


Tyr Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu 
65                  70                  75                  80  


Glu Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
                85                  90                  95      


Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile 
            100                 105                 110         


Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala 
        115                 120                 125             


Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe 
    130                 135                 140                 


Ser Gln Ser Ile Ile Ser Thr Leu Thr 
145                 150             


<210>  252
<211>  153
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein 2f

<400>  252

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu 
            20                  25                  30          


Gln Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile 
        35                  40                  45              


Asn Asn Tyr Lys Asn Pro Lys Leu Thr Phe Gly Asn Ser Thr Lys Phe 
    50                  55                  60                  


Tyr Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu 
65                  70                  75                  80  


Glu Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
                85                  90                  95      


Asn Phe His Leu Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile 
            100                 105                 110         


Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala 
        115                 120                 125             


Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe 
    130                 135                 140                 


Ser Gln Ser Ile Ile Ser Thr Leu Thr 
145                 150             


<210>  253
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  example peptide sequence

<400>  253

Ala Leu Met Gly Arg 
1               5   


<210>  254
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NX3X4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  254

Xaa Xaa Asn Xaa Xaa 
1               5   


<210>  255
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X2NX3X4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  threonine, serine or cysteine

<400>  255

Xaa Asn Xaa Xaa 
1               


<210>  256
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  X2NX3T


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  256

Xaa Asn Xaa Thr 
1               


<210>  257
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X2NX3S


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  257

Xaa Asn Xaa Ser 
1               


<210>  258
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X2NX3C


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  258

Xaa Asn Xaa Cys 
1               


<210>  259
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X2NSX4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  threonine, serine or cysteine

<400>  259

Xaa Asn Ser Xaa 
1               


<210>  260
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X2NST


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  260

Xaa Asn Ser Thr 
1               


<210>  261
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X2NSS


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  261

Xaa Asn Ser Ser 
1               


<210>  262
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X2NSC


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  262

Xaa Asn Ser Cys 
1               


<210>  263
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNX3X4


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  threonine, serine and cysteine

<400>  263

Gly Asn Xaa Xaa 
1               


<210>  264
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNX3T


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  264

Gly Asn Xaa Thr 
1               


<210>  265
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNX3S


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  265

Gly Asn Xaa Ser 
1               


<210>  266
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNX3C


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  266

Gly Asn Xaa Cys 
1               


<210>  267
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNSX4


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  threonine, serine or cysteine

<400>  267

Gly Asn Ser Xaa 
1               


<210>  268
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNST

<400>  268

Gly Asn Ser Thr 
1               


<210>  269
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNSS

<400>  269

Gly Asn Ser Ser 
1               


<210>  270
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif GNSC

<400>  270

Gly Asn Ser Cys 
1               


<210>  271
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANX3X4


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  threonine, serine or cysteine

<400>  271

Ala Asn Xaa Xaa 
1               


<210>  272
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANX3T


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  272

Ala Asn Xaa Thr 
1               


<210>  273
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANX3S


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  273

Ala Asn Xaa Ser 
1               


<210>  274
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANX3C


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  274

Ala Asn Xaa Cys 
1               


<210>  275
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANSX4


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  threonine, serine or cysteine

<400>  275

Ala Asn Ser Xaa 
1               


<210>  276
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANSC

<400>  276

Ala Asn Ser Cys 
1               


<210>  277
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANST

<400>  277

Ala Asn Ser Thr 
1               


<210>  278
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif ANSS

<400>  278

Ala Asn Ser Ser 
1               


<210>  279
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NX3T


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  279

Xaa Xaa Asn Xaa Thr 
1               5   


<210>  280
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NX3S


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  280

Xaa Xaa Asn Xaa Ser 
1               5   


<210>  281
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NX3C


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  281

Xaa Xaa Asn Xaa Cys 
1               5   


<210>  282
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NSX4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  282

Xaa Xaa Asn Ser Xaa 
1               5   


<210>  283
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NST


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  283

Xaa Xaa Asn Ser Thr 
1               5   


<210>  284
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NSS


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  284

Xaa Xaa Asn Ser Ser 
1               5   


<210>  285
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1X2NSC


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  285

Xaa Xaa Asn Ser Cys 
1               5   


<210>  286
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNX3X4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  286

Xaa Gly Asn Xaa Xaa 
1               5   


<210>  287
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNX3T


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  287

Xaa Gly Asn Xaa Thr 
1               5   


<210>  288
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNX3S


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  288

Xaa Gly Asn Xaa Ser 
1               5   


<210>  289
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNX3C


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  289

Xaa Gly Asn Xaa Cys 
1               5   


<210>  290
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNSX4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  290

Xaa Gly Asn Ser Xaa 
1               5   


<210>  291
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNST


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  291

Xaa Gly Asn Ser Thr 
1               5   


<210>  292
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNSS


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  292

Xaa Gly Asn Ser Ser 
1               5   


<210>  293
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1GNSC


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  293

Xaa Gly Asn Ser Cys 
1               5   


<210>  294
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3X4


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  294

Phe Xaa Asn Xaa Xaa 
1               5   


<210>  295
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3T


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  295

Phe Xaa Asn Xaa Thr 
1               5   


<210>  296
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3S


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  296

Phe Xaa Asn Xaa Ser 
1               5   


<210>  297
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3C


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  297

Phe Xaa Asn Xaa Cys 
1               5   


<210>  298
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NSX4


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  298

Phe Xaa Asn Ser Xaa 
1               5   


<210>  299
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NST


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  299

Phe Xaa Asn Ser Thr 
1               5   


<210>  300
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NSS


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  300

Phe Xaa Asn Ser Ser 
1               5   


<210>  301
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NSC


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  301

Phe Xaa Asn Ser Cys 
1               5   


<210>  302
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNX3X4


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  302

Phe Gly Asn Xaa Xaa 
1               5   


<210>  303
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNX3T


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  303

Phe Gly Asn Xaa Thr 
1               5   


<210>  304
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNX3S


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  304

Phe Gly Asn Xaa Ser 
1               5   


<210>  305
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNX3C


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  305

Phe Gly Asn Xaa Cys 
1               5   


<210>  306
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNSX4


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  306

Phe Gly Asn Ser Xaa 
1               5   


<210>  307
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNST

<400>  307

Phe Gly Asn Ser Thr 
1               5   


<210>  308
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNSS

<400>  308

Phe Gly Asn Ser Ser 
1               5   


<210>  309
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FGNSC

<400>  309

Phe Gly Asn Ser Cys 
1               5   


<210>  310
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANX3X4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  310

Xaa Ala Asn Xaa Xaa 
1               5   


<210>  311
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANX3T


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  311

Xaa Ala Asn Xaa Thr 
1               5   


<210>  312
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANX3S


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  312

Xaa Ala Asn Xaa Ser 
1               5   


<210>  313
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANX3C


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or is absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  313

Xaa Ala Asn Xaa Cys 
1               5   


<210>  314
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANSX4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  threonine, serine or cysteine

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa can be any naturally occurring amino acid

<400>  314

Xaa Ala Asn Ser Xaa 
1               5   


<210>  315
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANST


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  315

Xaa Ala Asn Ser Thr 
1               5   


<210>  316
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANSS


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or is absent

<400>  316

Xaa Ala Asn Ser Ser 
1               5   


<210>  317
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif X1ANSC


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  317

Xaa Ala Asn Ser Cys 
1               5   


<210>  318
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3X4


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  318

Phe Xaa Asn Xaa Xaa 
1               5   


<210>  319
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3T


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  319

Phe Xaa Asn Xaa Thr 
1               5   


<210>  320
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3S


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  320

Phe Xaa Asn Xaa Ser 
1               5   


<210>  321
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NX3C


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  321

Phe Xaa Asn Xaa Cys 
1               5   


<210>  322
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NSX4


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  322

Phe Xaa Asn Ser Xaa 
1               5   


<210>  323
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NST


<220>
<221>  MISC_FEATURE
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  323

Phe Xaa Asn Ser Thr 
1               5   


<210>  324
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NSS


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or absent

<400>  324

Phe Xaa Asn Ser Ser 
1               5   


<210>  325
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FX2NSC


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  any proteinogenic or non-proteinogenic amino acid or is absent

<400>  325

Phe Xaa Asn Ser Cys 
1               5   


<210>  326
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANX3X4


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  326

Phe Ala Asn Xaa Xaa 
1               5   


<210>  327
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANX3T


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  327

Phe Ala Asn Xaa Thr 
1               5   


<210>  328
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANX3S


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  328

Phe Ala Asn Xaa Ser 
1               5   


<210>  329
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANX3C


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  any proteinogenic or non-proteinogenic amino acid except proline

<400>  329

Phe Ala Asn Xaa Cys 
1               5   


<210>  330
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANSX4


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  threonine, serine or cysteine

<400>  330

Phe Ala Asn Ser Xaa 
1               5   


<210>  331
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANST

<400>  331

Phe Ala Asn Ser Thr 
1               5   


<210>  332
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANSS

<400>  332

Phe Ala Asn Ser Ser 
1               5   


<210>  333
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycosylation motif FANSC

<400>  333

Phe Ala Asn Ser Cys 
1               5   


<210>  334
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  334

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Gly Asp Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  335
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  335

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Phe Ala Asp Ser Thr Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  336
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  336

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Gly Asp Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  337
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  337

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Phe Ala Asp Ser Thr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys Pro 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  338
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  338

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asp Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  339
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  339

Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His Leu 
1               5                   10                  15      


Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys Asn 
            20                  25                  30          


Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys Lys 
        35                  40                  45              


Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asp Ser Thr 
    50                  55                  60                  


Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu Arg 
65                  70                  75                  80  


Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu Lys 
                85                  90                  95      


Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala Thr 
            100                 105                 110         


Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile Ile 
        115                 120                 125             


Ser Thr Leu Thr 
    130         


<210>  340
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  340

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Gly Asp Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  341
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  341

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Phe Ala Asp Ser Thr Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  342
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  342

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asp Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  343
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  343

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Phe Ala Asp Ser Thr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu Leu Lys 
    50                  55                  60                  


Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  344
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  344

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly Asp Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  345
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IL-2 protein of formula (I-ii)

<400>  345

Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu Gln Leu Glu His 
1               5                   10                  15      


Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile Asn Asn Tyr Lys 
            20                  25                  30          


Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met Pro Lys 
        35                  40                  45              


Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala Asp Ser 
    50                  55                  60                  


Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys Asn Phe His Leu 
65                  70                  75                  80  


Arg Pro Arg Asp Leu Ile Ser Asn Ile Asn Val Ile Val Leu Glu Leu 
                85                  90                  95      


Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala Asp Glu Thr Ala 
            100                 105                 110         


Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe Ser Gln Ser Ile 
        115                 120                 125             


Ile Ser Thr Leu Thr 
    130             


<210>  346
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  346

Tyr Lys Asn Pro Phe Ala Asp Ser Thr Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  347
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  347

Tyr Lys Asn Pro Lys Leu Thr Phe Ala Asp Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  348
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  348

Tyr Lys Asn Pro Lys Leu Thr Arg Phe Ala Asp Ser Thr Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  349
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  349

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Phe Ala Asp Ser Thr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  350
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  350

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Ala Asp Ser Thr 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  351
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  351

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Phe Ala Asp Ser 
1               5                   10                  15      


Thr Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  352
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  352

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Ala Asp 
1               5                   10                  15      


Ser Thr Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  353
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  353

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Phe Ala 
1               5                   10                  15      


Asp Ser Thr Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  354
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  354

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Ala 
            20                  25                  30          


Asp Ser Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  355
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  355

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Phe 
            20                  25                  30          


Ala Asp Ser Thr Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  356
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  356

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Phe Ala Asp Ser Thr 
        35                  40                  45      


<210>  357
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  357

Tyr Lys Asn Pro Phe Gly Asp Ser Thr Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  358
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  358

Tyr Lys Asn Pro Lys Leu Thr Phe Gly Asp Ser Thr Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  359
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  359

Tyr Lys Asn Pro Lys Leu Thr Arg Phe Gly Asp Ser Thr Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  360
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  360

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Phe Gly Asp Ser Thr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  361
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  361

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Gly Asp Ser Thr 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  362
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  362

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Phe Gly Asp Ser 
1               5                   10                  15      


Thr Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  363
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  363

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Gly Asp 
1               5                   10                  15      


Ser Thr Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  364
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  364

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Phe Gly 
1               5                   10                  15      


Asp Ser Thr Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  365
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  365

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Phe Gly 
            20                  25                  30          


Asp Ser Thr Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  366
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  366

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Phe 
            20                  25                  30          


Gly Asp Ser Thr Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
        35                  40                  45      


<210>  367
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SEQ D

<400>  367

Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe Tyr Met 
1               5                   10                  15      


Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu Glu Glu 
            20                  25                  30          


Leu Lys Pro Leu Glu Glu Val Leu Asn Phe Gly Asp Ser Thr 
        35                  40                  45      


<210>  368
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  example sequence

<400>  368

Phe Gly Asp Ser Thr 
1               5   


